Aim: The aim of this article was to find the differences between level of anxiety, level of depression and certain features of self-image during relapse and remission in multiple sclerosis patients.
Method: Subjects were 42 patients of the Neurology Department at the Military Hospital in Lublin with relapsing--remitting multiple sclerosis (RR-MS); 26 patients in relapse and 16 in remission of the disease. All patients included into the study had a diagnosis of multiple sclerosis according to the McDonald criteria. Mean age of the studied patients was 36 years, mean disease duration--8 years. Patients were investigated with the use of Beck Depression Inventory, State-Trait Anxiety Inventory (STAI), Gough and Heilbrunn Adjective Check List (ACL)--a questionnaire designed for the study.
Results: . Using the T-Student test, we compared results from MS patients in the period of relapse and in remission. Our results revealed statistically significant differences in the level of anxiety in State Trait Anxiety Inventory (STAI) and in Free Child (FC) scale of Adjective Check List (ACL).
Conclusions: Our results show that patients in relapse have a higher level of anxiety, more negative attitude towards themselves, lack of self-confidence and they isolate more from the society as compared to multiple sclerosis patients in remission.
Download full-text PDF |
Source |
---|
Front Immunol
January 2025
Environmental Factors in Degenerative Diseases Research Group. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Introduction: The envelope proteins syncytin-1 and pHERV-W from the Human Endogenous Retroviral family 'W' (HERV-W) have been identified as potential risk factors in multiple sclerosis (MS). This study aims to evaluate both humoral and cell-mediated immune response to antigenic peptides derived from these proteins across different clinical forms and inflammatory phases of MS.
Methods: Indirect enzyme-linked immunosorbent assay (ELISA) was employed to measure immunoglobulin G (IgG) responses to syncytin-1 and pHERV-W peptides in MS patients.
Explor Neuroprotective Ther
April 2024
School of Nursing, University of Michigan, Ann Arbor, MI 48109, USA.
Aim: Childhood stressors can increase adult stress perception and may accumulate over the lifespan to impact symptoms of multiple sclerosis (MS). Growing evidence links childhood stressors (e.g.
View Article and Find Full Text PDFJ Educ Health Promot
December 2024
Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: The plethora of troublesome signs and symptoms of multiple sclerosis (MS) reduces patients' quality of life (QOL) and coping skills. Face-to-face (F2F) education is effective and practical as it allows for more engagement and active learning. The use of mobile health technology to enhance health is now an excellent potential to establish a more efficient health system.
View Article and Find Full Text PDFNeurodegener Dis Manag
January 2025
dMerck Healthcare KGaA, Darmstadt, Germany.
J Diet Suppl
January 2025
LINP2, UFR STAPS, University of Paris Nanterre, Nanterre, France.
Our previous study revealed the benefits of chronic melatonin intake on dynamic postural imbalance and poor walking capacity induced by multiple sclerosis but its impact on muscle weakness and poor manual dexterity related to this disease has not yet been explored. The objective of the current study was to investigate the effectiveness of 12-week melatonin supplementation on motor skills (i.e.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!